Skip to content
  • Home
  • Our Story
  • The Science
  • Leadership
  • Careers
  • News
  • Contact
  • Home
  • Our Story
  • The Science
  • Leadership
  • Careers
  • News
  • Contact

Medytox, Inc. Announces the Formation of Luvantas Subsidiary and Appointment of Key Executives

IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ — Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned

Read More

Medytox submits BLA for non-animal-derived liquid BTX formulation in US

Medytox said it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for MT10109L, a non-animal-derived liquid botulinum toxin (BTX) formulation indicated for improving moderate to severe frown lines and crow’s feet.

Read More

© 2025 Luvantas® All rights reserved. All trademarks are the property of their respective owners.

  • Privacy Policy
  • Terms of Use
  • Site Design by Leftcoast Studios
  • Privacy Policy
  • Terms of Use
  • Site Design by Leftcoast Studios

© 2025 Luvantas® All rights reserved. All trademarks are the property of their respective owners.

  • Privacy Policy
  • Terms of Use
  • Site Design by Leftcoast Studios
  • Privacy Policy
  • Terms of Use
  • Site Design by Leftcoast Studios